Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research

NL Benowitz, ML Goniewicz… - The Lancet …, 2022 - thelancet.com
Heterogeneity in the clinical presentation of SARS-CoV-2 infection and COVID-19
progression underscores the urgent need to identify individual-level susceptibility factors …

Effectiveness of BNT162b2 XBB vaccine in the US veterans affairs healthcare system

AR Caffrey, HJ Appaneal, VV Lopes, L Puzniak… - Nature …, 2024 - nature.com
Data evaluating effectiveness of XBB. 1.5-adapted vaccines against JN. 1-related endpoints
are scarce. This nationwide test-negative case-control study within the US Veterans Affairs …

Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community

AD Abukhalil, SS Shatat, RR Abushehadeh… - BMC Infectious …, 2023 - Springer
Abstract Background The Pfizer BioNTech COVID-19 vaccine was the first to receive
emergency authorization and approval from the FDA. Therefore, it is preferred by most …

SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia

M Karachaliou, G Moncunill, A Espinosa… - BMC medicine, 2022 - Springer
Background Heterogeneity of the population in relation to infection, COVID-19 vaccination,
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody …

Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment

M Augello, I Wagenhäuser, M Krone, N Dauby… - Vaccine, 2024 - Elsevier
Abstract Anti–SARS-CoV-2 vaccination has saved millions of lives in the past few years. To
maintain a high level of protection, particularly in at-risk populations, booster doses are …

Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study

AA Prather, EG Dutcher, J Robinson, J Lin… - Scientific reports, 2023 - nature.com
As concerns related to the COVID-19 pandemic continue, it is critical to understand the
impact of vaccination type on neutralizing antibody response durability as well as to identify …

Factors associated with receipt of COVID-19 vaccination and SARS-CoV-2 seropositivity among healthcare workers in Albania (February 2021–June 2022) …

P Jorgensen, A Schmid, J Sulo, I Preza… - The Lancet Regional …, 2023 - thelancet.com
Summary Background Healthcare workers (HCWs) have been disproportionally affected by
COVID-19. We investigated factors associated with two-and three-dose COVID-19 vaccine …

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine …

LF López-Cortés, A Saborido-Alconchel… - Frontiers in …, 2023 - frontiersin.org
Background Data on SARS-CoV-2 mRNA vaccine immunogenicity in people living with
human immunodeficiency virus (PLWH) and discordant immune response (DIR) are …

[HTML][HTML] Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV

F Chammartin, K Kusejko, C Pasin, A Trkola, M Briel… - Aids, 2022 - journals.lww.com
We identified determinants of SARS-CoV-2 mRNA vaccine antibody response in people with
HIV (PWH). Antibody response was higher among PWH less than 60 years, with CD4+ cell …

Antibiotic use prior to COVID-19 vaccine is associated with higher risk of COVID-19 and adverse outcomes: a propensity-scored matched territory-wide cohort

KS Cheung, VKC Yan, LK Lam, X Ye, IFN Hung… - Vaccines, 2023 - mdpi.com
Background: Antibiotics may increase the risk of COVID-19 among non-vaccinated subjects
via probable gut dysbiosis. We aimed to investigate whether antibiotics also affect the …